XML 43 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
Portfolio Loans Not Covered by Loss Share ("Non-covered") - Summary of Recorded Investment in Non-covered Loans by Portfolio Class and Category Based on Impairment Method (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 31, 2013
Jun. 30, 2014
Non-Covered Loans
Mar. 31, 2014
Non-Covered Loans
Dec. 31, 2013
Non-Covered Loans
Jun. 30, 2014
Non-Covered Loans
Commercial & Industrial
Mar. 31, 2014
Non-Covered Loans
Commercial & Industrial
Dec. 31, 2013
Non-Covered Loans
Commercial & Industrial
Jun. 30, 2014
Non-Covered Loans
Commercial Real Estate Owner Occupied
Mar. 31, 2014
Non-Covered Loans
Commercial Real Estate Owner Occupied
Dec. 31, 2013
Non-Covered Loans
Commercial Real Estate Owner Occupied
Jun. 30, 2014
Non-Covered Loans
Commercial Real Estate Investor Owned
Mar. 31, 2014
Non-Covered Loans
Commercial Real Estate Investor Owned
Dec. 31, 2013
Non-Covered Loans
Commercial Real Estate Investor Owned
Jun. 30, 2014
Non-Covered Loans
Construction and Land Development
Mar. 31, 2014
Non-Covered Loans
Construction and Land Development
Dec. 31, 2013
Non-Covered Loans
Construction and Land Development
Jun. 30, 2014
Non-Covered Loans
Residential Real Estate
Mar. 31, 2014
Non-Covered Loans
Residential Real Estate
Dec. 31, 2013
Non-Covered Loans
Residential Real Estate
Jun. 30, 2014
Non-Covered Loans
Consumer & Other
Mar. 31, 2014
Non-Covered Loans
Consumer & Other
Dec. 31, 2013
Non-Covered Loans
Consumer & Other
Summary of Recorded Investment in Non-covered Loans by Portfolio Class and Category Based on Impairment Method [Line Items]                                                    
Impaired Financing Receivable, Interest Income, Accrual Method $ 6,000 $ 0 $ 15,000 $ 29,000                                            
Allowance for Loan Losses - Ending Balance:                                                    
Individually evaluated for impairment           1,861,000   1,550,000 1,178,000   736,000 298,000   107,000 0   0 375,000   703,000 10,000   4,000 0   0
Collectively evaluated for impairment           26,561,000   25,739,000 13,897,000   11,510,000 3,723,000   3,989,000 4,330,000   6,600,000 1,780,000   1,433,000 2,517,000   2,015,000 314,000   192,000
Total           28,422,000 27,905,000 27,289,000 15,075,000 12,858,000 12,246,000 4,021,000 4,357,000 4,096,000 4,330,000 6,375,000 6,600,000 2,155,000 1,987,000 2,136,000 2,527,000 2,076,000 2,019,000 314,000 252,000 192,000
Loans - Ending Balance:                                                    
Individually evaluated for Impairment           22,065,000   20,840,000 4,649,000   3,380,000 4,276,000   606,000 5,174,000   6,811,000 7,422,000   9,484,000 544,000   559,000 0   0
Collectively evaluated for impairment           2,229,037,000   2,116,473,000 1,130,420,000   1,038,196,000 365,107,000   341,025,000 380,914,000   430,877,000 129,621,000   107,548,000 173,420,000   157,968,000 49,555,000   40,859,000
Total           2,250,023,000   2,136,292,000 1,135,069,000   1,041,576,000 369,383,000   341,631,000 386,088,000   437,688,000 137,043,000   117,032,000 173,964,000   158,527,000 48,476,000   39,838,000
Total $ 2,251,102,000   $ 2,251,102,000   $ 2,137,313,000 $ 2,251,102,000   $ 2,137,313,000                               $ 49,555,000   $ 40,859,000